MedPlus Health Services Future Growth
Future criteria checks 2/6
MedPlus Health Services is forecast to grow earnings and revenue by 12.7% and 11.7% per annum respectively. EPS is expected to grow by 12.7% per annum. Return on equity is forecast to be 12.6% in 3 years.
Key information
12.7%
Earnings growth rate
12.69%
EPS growth rate
| Consumer Retailing earnings growth | 21.6% |
| Revenue growth rate | 11.7% |
| Future return on equity | 12.60% |
| Analyst coverage | Good |
| Last updated | 04 Nov 2025 |
Recent future growth updates
MedPlus Health Services Limited Just Beat EPS By 13%: Here's What Analysts Think Will Happen Next
Nov 05
Earnings Beat: MedPlus Health Services Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Aug 06₹1,053 - That's What Analysts Think MedPlus Health Services Limited (NSE:MEDPLUS) Is Worth After These Results
May 31MedPlus Health Services Limited (NSE:MEDPLUS) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year
Feb 05Recent updates
MedPlus Health Services Limited Just Beat EPS By 13%: Here's What Analysts Think Will Happen Next
Nov 05MedPlus Health Services' (NSE:MEDPLUS) Returns On Capital Not Reflecting Well On The Business
Sep 25Earnings Beat: MedPlus Health Services Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Aug 06Market Participants Recognise MedPlus Health Services Limited's (NSE:MEDPLUS) Earnings
Jul 16₹1,053 - That's What Analysts Think MedPlus Health Services Limited (NSE:MEDPLUS) Is Worth After These Results
May 31Here's What's Concerning About MedPlus Health Services' (NSE:MEDPLUS) Returns On Capital
May 18MedPlus Health Services Limited's (NSE:MEDPLUS) P/E Still Appears To Be Reasonable
Mar 26
Opening 600 New Stores And Improving Operations Will Expand Future Market Reach
Expansion with new warehouses and 600 stores will enhance supply chain, boost revenue, and drive significant top-line growth.MedPlus Health Services Limited (NSE:MEDPLUS) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year
Feb 05A Look At The Fair Value Of MedPlus Health Services Limited (NSE:MEDPLUS)
Jan 28Even With A 27% Surge, Cautious Investors Are Not Rewarding MedPlus Health Services Limited's (NSE:MEDPLUS) Performance Completely
Dec 05There Are Reasons To Feel Uneasy About MedPlus Health Services' (NSE:MEDPLUS) Returns On Capital
Aug 30Is Now The Time To Put MedPlus Health Services (NSE:MEDPLUS) On Your Watchlist?
Feb 03MedPlus Health Services (NSE:MEDPLUS) Will Want To Turn Around Its Return Trends
Dec 11A Look At The Intrinsic Value Of MedPlus Health Services Limited (NSE:MEDPLUS)
Oct 24The Returns On Capital At MedPlus Health Services (NSE:MEDPLUS) Don't Inspire Confidence
Jul 18Why Investors Shouldn't Be Surprised By MedPlus Health Services Limited's (NSE:MEDPLUS) P/S
Jun 22A Look At The Fair Value Of MedPlus Health Services Limited (NSE:MEDPLUS)
Apr 18MedPlus Health Services (NSE:MEDPLUS) Could Be Struggling To Allocate Capital
Feb 08₹1,177: That's What Analysts Think MedPlus Health Services Limited (NSE:MEDPLUS) Is Worth After Its Latest Results
Jun 03Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2028 | 85,387 | 2,648 | 5,763 | 6,047 | 5 |
| 3/31/2027 | 75,482 | 2,201 | 4,667 | 5,088 | 6 |
| 3/31/2026 | 67,635 | 1,937 | 4,621 | 5,070 | 7 |
| 9/30/2025 | 62,930 | 1,951 | 5,080 | 5,811 | N/A |
| 6/30/2025 | 61,899 | 1,783 | N/A | N/A | N/A |
| 3/31/2025 | 61,361 | 1,503 | 4,810 | 5,404 | N/A |
| 12/31/2024 | 61,169 | 1,324 | N/A | N/A | N/A |
| 9/30/2024 | 59,970 | 1,002 | 2,827 | 3,544 | N/A |
| 6/30/2024 | 58,294 | 761 | N/A | N/A | N/A |
| 3/31/2024 | 56,249 | 655 | 593 | 1,437 | N/A |
| 12/31/2023 | 53,873 | 587 | N/A | N/A | N/A |
| 9/30/2023 | 51,362 | 583 | -65 | 1,086 | N/A |
| 6/30/2023 | 48,482 | 503 | N/A | N/A | N/A |
| 3/31/2023 | 45,576 | 498 | -786 | 904 | N/A |
| 12/31/2022 | 42,705 | 349 | N/A | N/A | N/A |
| 9/30/2022 | 40,136 | 387 | -1,113 | 572 | N/A |
| 6/30/2022 | 38,178 | 524 | N/A | N/A | N/A |
| 3/31/2022 | 37,793 | 958 | 522 | 1,699 | N/A |
| 12/31/2021 | 36,191 | 1,024 | N/A | N/A | N/A |
| 9/30/2021 | 34,866 | 1,082 | 643 | 1,538 | N/A |
| 6/30/2021 | 32,932 | 991 | N/A | N/A | N/A |
| 3/31/2021 | 30,693 | 639 | -514 | 29 | N/A |
| 3/31/2020 | 28,706 | 22 | -368 | -66 | N/A |
| 3/31/2019 | 22,727 | 119 | N/A | 1,467 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MEDPLUS's forecast earnings growth (12.7% per year) is above the savings rate (6.8%).
Earnings vs Market: MEDPLUS's earnings (12.7% per year) are forecast to grow slower than the Indian market (16.6% per year).
High Growth Earnings: MEDPLUS's earnings are forecast to grow, but not significantly.
Revenue vs Market: MEDPLUS's revenue (11.7% per year) is forecast to grow faster than the Indian market (10.9% per year).
High Growth Revenue: MEDPLUS's revenue (11.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MEDPLUS's Return on Equity is forecast to be low in 3 years time (12.6%).
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/20 12:06 |
| End of Day Share Price | 2025/11/20 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
MedPlus Health Services Limited is covered by 15 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Vijayaraghavan Swaminathan | Avendus Spark |
| Harith Ahamed | Avendus Spark |
| null null | Axis Capital Limited |